Pacifica Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Pacifica Partners's GILD Position: Q3 2026 in Review
Pacifica Partners held its Gilead Sciences (GILD) position steady in Q3 2026 at 310 shares worth $45.7K. The position accounts for 0.01% of the portfolio, ranked #189.
Pacifica Partners first reported a position in GILD in Q4 2019 and has held it in 28 quarters since. The position peaked at $45.7K in Q1 2026. 664 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Pacifica Partners held 310 shares of Gilead Sciences worth $45.7K as of Q3 2026.
- Pacifica Partners left its Gilead Sciences share count unchanged in Q3 2026.
- Gilead Sciences made up 0.01% of Pacifica Partners's portfolio in Q3 2026, its #189 holding.
- Pacifica Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 28 quarters since.
- Pacifica Partners's Gilead Sciences position peaked at $45.7K in Q1 2026.
- 664 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.